1. Global Initiative for Asthma: Global strategy for asthma management and prevention, NHLBI/WHO Workshop Report, National Institute of Health, National Heart, Lung and Blood Institute, January 1995
2. Short-acting β2versus long-acting β2agonists;Chazan;Int Rev Allergol Clin Immunol,1998
3. Oxis®(formoterol) Turbuhaler®: its pharmacological and clinical properties;Selroos;Eur Respir Rev,1998
4. Salmeterol, a new long acting inhaled β2adrenoreceptor agonist: comparison with salbutamol in adult asthmatic patients;Ullman;Thorax,1988
5. A direct comparison of the time of onset of action between inhaled formoterol and salmeterol;Linsen;Eur Respir J,1993